Portuguese
Russian
German
Spanish
French
English
Menu
食品菌种与酶
鲜乳
深刻见解和理念
创造价值
我们的产品
奶酪
深刻见解和理念
创造价值
我们的产品
肉类和海鲜
创造价值
我们的产品
检测及设备
创造价值
我们的产品
发酵饮料
深刻见解与理念
创造价值
我们的产品
联系我们，了解我们的产品
生物保鲜技术
洞察力和理念
创造价值
我们的产品
Fermented plant bases
Insights & concepts
Creating value
Our products
最新信息
Global distributors FCE
天然色素
农艺和天然色素
采购
培育
Hansen sweet potato™
应用专业知识
饮料
乳制品和水果制品
膳食补充剂
糖果
冰淇淋
Prepared food
宠物食品
彩虹般的颜色
红色 - 紫罗兰色 - 紫色
黄色 - 橙色
蓝色 - 绿色
白色 - 黑色 - 棕色
与您合作
品质承诺
协作是我们的核心理念
天然色素使您的品牌与众不同
植物健康
为什么农作物需要微生物？
Nature´s no. 1
天然和健康的解决方案
协作
FMC联盟
联盟推出的产品
PRESENCE® 杀线虫剂
QUARTZO® 生物杀线虫剂
NEMIX® C
Capture™ LFR® Plus VGR™
规模和生产的不断壮大
Animal Health
Swine
Science based
Research proven
Probiotic solutions
Swine health news
Poultry
Science based
Research proven
Probiotic solutions
Poultry health news
Dairy
Science based
Research proven
Silage inoculants
Dairy health news
Beef
Science based, Beef
Research proven, Beef
Silage inoculants, Beef
Beef health news
Animal Health News
Global Distributors
Customer challenges
益生菌补充剂和婴儿配方食品
市场洞察以及产品服务
市场趋势
目标人群
Probiotic product areas
PROBIO-TEC®产品
菌群
有文献记录的益生菌
PROBIO-TEC®益生菌 – 我们的3 USP
我们的益生菌菌株
临床文件
稳定性是关键
什么是益生菌？
我们的专业知识 - 您的机会
我们的服务 – 3 I
伙伴关系
Production & quality
内部专家
人类健康新闻
关于我们
目标和战略
我们的文化
历史
管理团队
Board of directors
委员会
Executive board & corporate leadership team
创新, 研究与开发
我们的科技基础
外部协作
出版物
联系研发团队
政策和立场
采购
供应商管理
类别管理
电子互动
Purchase terms & conditions
联系方式
招贤纳士
加入我们
空缺职位
自荐求职
学术伙伴
招聘和入职
职业规划和人才培养
职业规划和升职机会
人才培养
在科汉森工作
媒体
社群媒体
我们的视频
联系人
Sustainability
The secret weapon against flu-like sickness
Innovating for a sustainable future
反对食物浪费
Partnering for impact
A regenerative agriculture
Access to affordable and healthy food
Global advocacy
Targets & governance
Our contribution to the UN Global Goals
Our operations
Governance and anchoring
Reporting and rankings
Reporting and disclosure
Rankings and awards
Investors
Business
Fact sheet
Strategy
Financial results
Outlook & long-term ambitions
Share info
Ownership
Capital allocation
Investment calculator
Analyst coverage
Consensus
ADR
Governance
Remuneration
Corporate governance
Annual General Meeting
Policies & charters
Risk management
Responsible investing
Reports & presentations
Company announcements & news
Financial calendar
Subscription
Contact
关于我们
目标和战略
我们的文化
历史
管理团队
Board of directors
委员会
Executive board & corporate leadership team
创新, 研究与开发
我们的科技基础
外部协作
出版物
联系研发团队
政策和立场
采购
供应商管理
类别管理
电子互动
Purchase terms & conditions
联系方式
招贤纳士
加入我们
空缺职位
自荐求职
学术伙伴
招聘和入职
职业规划和人才培养
职业规划和升职机会
人才培养
在科汉森工作
媒体
社群媒体
我们的视频
联系人
Sustainability
The secret weapon against flu-like sickness
Innovating for a sustainable future
反对食物浪费
Partnering for impact
A regenerative agriculture
Access to affordable and healthy food
Global advocacy
Targets & governance
Our contribution to the UN Global Goals
Our operations
Governance and anchoring
Reporting and rankings
Reporting and disclosure
Rankings and awards
Investors
Business
Fact sheet
Strategy
Financial results
Outlook & long-term ambitions
Share info
Ownership
Capital allocation
Investment calculator
Analyst coverage
Consensus
ADR
Governance
Remuneration
Corporate governance
Annual General Meeting
Policies & charters
Risk management
Responsible investing
Reports & presentations
Company announcements & news
Financial calendar
Subscription
Contact
Chinese
Portuguese
Russian
German
Spanish
French
English
登录
Sustainability
A new study reveals a secret weapon to reduce the cost of flu-like sickness
Corporate News
Solid sales growth and profitability in Q3, but reduced organic growth outlook for the year
Corporate news
Chr. Hansen ranked as the most sustainable company in the world
动物健康
科汉森动物健康业务部发布的科学出版物达到100 份，实现重要里程碑
Research & development
Chr. Hansen scientists contribute to prestigious scientific journal
动物健康
科汉森动物健康业务部发布的科学出版物达到100 份，实现重要里程碑
Upcoming events
October
10
Annual Report 2018/19
Date:
10 October
Location:
Hoersholm, Danmark
November
27
Annual General Meeting 2019
Date:
27 November
Location:
Hoersholm, Danmark
January
15
Interim Report Q1 2019/20
Date:
15 January
Location:
Hoersholm, Danmark
Latest press releases
August
29
Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products
August
29
Chr. Hansen gearer op til en bæredygtig fremtid
August
29
Chr. Hansen gears up for a sustainable future
